Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001066460 | SCV001231471 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-08-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001539628 | SCV001757423 | uncertain significance | not provided | 2021-06-25 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 860191; Landrum et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26582918, 27535533) |
Ambry Genetics | RCV002339331 | SCV002619269 | uncertain significance | Cardiovascular phenotype | 2021-08-23 | criteria provided, single submitter | clinical testing | The p.R1195S variant (also known as c.3583C>A), located in coding exon 24 of the MYH6 gene, results from a C to A substitution at nucleotide position 3583. The arginine at codon 1195 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |